Vectors Research Management’s Celgene Corp CELG Stock Holding History

Vectors Research Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	-$40K	–	582
2019 Q3	$40K	Hold	400	–	–	0.02%	186
2019 Q2	$37K	Hold	400	–	–	0.02%	185
2019 Q1	$38K	Hold	400	–	–	0.02%	183
2018 Q4	$26K	Sell	400 -53	-12%	-$3.91K	0.01%	274
2018 Q3	$36K	Buy	+453	New	+$40K	0.02%	199

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Vectors Research Management's CELG Position: Q4 2019 in Review

Vectors Research Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 400 shares — an estimated $40K sold.

Vectors Research Management first reported a position in CELG in Q3 2018 and held it in 5 quarters. The position peaked at $40K in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Vectors Research Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Vectors Research Management sold 400 Celgene Corp shares in Q4 2019, an estimated $40K.
Vectors Research Management first reported a position in Celgene Corp in Q3 2018 and held it in 5 quarters.
Vectors Research Management's Celgene Corp position peaked at $40K in Q3 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Vectors Research Management's 13F filing for Q4 2019, filed 14 Feb 2020.